The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants
One in eight women will develop breast cancer (BC) over their lifetime. Triple-negative breast cancer (TNBC) accounts for up to 20% of BC cases and has fewer treatment options, greater metastatic potential, a higher risk of recurrence, and a poorer prognosis compared to other BC subtypes. Compared t...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2026-12-01
|
| Sarja: | Cancer Biology & Therapy |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/15384047.2026.2683942 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
